1Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies [J]. N Engl J Med, 1993,328(25):1828-1835.
2Brenner DA. Signal transduction during liver regeneration [ J ]. J Gastroenterol Hepatol, 1998,13 (Suppl): S93-95.
3Ga.lli A, Crabb D, Ceni E, et al. Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation in human hepatic stellate cells [ J ].Hepatology, 2000,31 (1): 101-108.
4Olaso E, Friedman L. Molecular regulation of hepatic fibrogenesis [J].J Hepatol, 1998,29(5) :836-847.
5Lehman JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferatoractivated receptor γ[J]. J Biol Chem, 1995,270(22): 12953-12956.
6Galli A, Crabb D, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro [J]. Gastroenterology,2002,122(7) . 1924-1940.
7Jiang C, Ting AT, Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines [ J ]. Nature, 1998,391 (6662): 82-86.
8Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38:S38-S53.
9Cassiman D, Roskams T. Beauty is in the eye of the beholder:emerging concepts ad pitfalls in hepatic stellate cell research.J Hepatol 2002; 37:527-535.
10Desmet V, Roskams T, Van Eyken P. Ductular reaction in the liver. Pathol Res Pract 1995; 191:513-524.
